Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioHarvest Sciences (TSE:BHSC)
CNQX:BHSC
RESEARCH TOOLSreports
Holding TSE:BHSC?
Track your performance easily
BHSC Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$5.60 - C$10.50
Previous CloseC$7.6
Volume1.20K
Average Volume (3M)2.06K
Market Cap
C$103.94M
Enterprise ValueC$117.35M
Total Cash (Recent Filing)$1.56M
Total Debt (Recent Filing)$11.43M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Nov 25, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.60
Shares Outstanding17,327,716
10 Day Avg. Volume3,739
30 Day Avg. Volume2,064
Standard Deviation0.22
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-16.89
Price to Sales (P/S)9.02
Price to Cash Flow (P/CF)-24.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.07
Enterprise Value/Gross Profit47.98
Enterprise Value/Ebitda-27.62
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioHarvest Sciences News
PremiumCompany Announcements
BioHarvest Sciences Executive Reshuffles for Nasdaq CompliancePremiumCompany Announcements
BioHarvest Sciences to Present at Investor Conference
PremiumCompany Announcements
BioHarvest Sciences Soars with Strong Q2 Growth
PremiumCompany Announcements
BioHarvest Sciences to Showcase at Global Investment Conference
PremiumCompany Announcements
BioHarvest Sciences Soars with Record Q2 Revenue
PremiumCompany Announcements
BioHarvest Sciences’ VINIA Coffee Hits $1M Sales
PremiumCompany Announcements
BioHarvest Sciences Secures Over $4M in FundingPremiumCompany Announcements
BioHarvest Sciences Initiates $5M Capital BoostBHSC FAQ
What was BioHarvest Sciences’s price range in the past 12 months?
BioHarvest Sciences lowest stock price was C$5.60 and its highest was C$10.50 in the past 12 months.
What is BioHarvest Sciences’s market cap?
Currently, no data Available
When is BioHarvest Sciences’s upcoming earnings report date?
BioHarvest Sciences’s upcoming earnings report date is Nov 25, 2024 which is in 66 days.
How were BioHarvest Sciences’s earnings last quarter?
BioHarvest Sciences released its earnings results on Aug 29, 2024. The company reported -C$0.054 earnings per share for the quarter, beating the consensus estimate of -C$0.136 by C$0.082.
Is BioHarvest Sciences overvalued?
According to Wall Street analysts BioHarvest Sciences’s price is currently Overvalued.
Does BioHarvest Sciences pay dividends?
BioHarvest Sciences does not currently pay dividends.
What is BioHarvest Sciences’s EPS estimate?
BioHarvest Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioHarvest Sciences have?
BioHarvest Sciences has 13,676,805 shares outstanding.
What happened to BioHarvest Sciences’s price movement after its last earnings report?
BioHarvest Sciences reported an EPS of -C$0.054 in its last earnings report, beating expectations of -C$0.136. Following the earnings report the stock price went up 0.685%.
Which hedge fund is a major shareholder of BioHarvest Sciences?
Currently, no hedge funds are holding shares in TSE:BHSC
---
BioHarvest Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth C$68.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
24.08%
12-Months-Change
Fundamentals
Return on Equity
-4296.45%
Trailing 12-Months
Asset Growth
165.49%
Trailing 12-Months
Company Description
BioHarvest Sciences
BioHarvest Sciences Inc is the developer and owner of the proprietary and patent protected Biofarming technology. It is the industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. The technology has been already validated by Vinia, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest. By adapting this technology to the Cannabis plant, and building adequate cells production capacity, the company's objective is to be the supplier of Cannabis for both the medicinal and recreational legal use.
---
Technical Analysis
---